Cargando…
Safety and efficacy of bone marrow derived-mesenchymal stem cells transplantation in patients with amyotrophic lateral sclerosis
Stem cell-based treatments have emerged as potentially effective approaches to delay the progression of amyotrophic lateral sclerosis (ALS). This study was designed as a single-center, prospective, and open-label study without a placebo control group to assess the safety and efficacy of concurrent i...
Autores principales: | Tavakol-Afshari, Jalil, Boroumand, Amir Reza, Farkhad, Najmeh Kaffash, Adhami Moghadam, Amir, Sahab-Negah, Sajad, Gorji, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society for Regenerative Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377537/ https://www.ncbi.nlm.nih.gov/pubmed/34466632 http://dx.doi.org/10.1016/j.reth.2021.07.006 |
Ejemplares similares
-
Mesenchymal stem cell therapy in amyotrophic lateral sclerosis (ALS) patients: A comprehensive review of disease information and future perspectives
por: Najafi, Shahrzad, et al.
Publicado: (2023) -
Are mesenchymal stem cells able to manage cytokine storm in COVID-19 patients? A review of recent studies
por: Kaffash Farkhad, Najmeh, et al.
Publicado: (2021) -
Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trial
por: Kaffash Farkhad, Najmeh, et al.
Publicado: (2022) -
Chromosomal Instability in Various Generations of Human Mesenchymal Stem Cells Following the Therapeutic Radiation
por: Sadeghi Moghadam, Majid, et al.
Publicado: (2023) -
Curcumin Loaded in Niosomal Nanoparticles Improved the Anti-tumor Effects of Free Curcumin on Glioblastoma Stem-like Cells: an In Vitro Study
por: Sahab-Negah, Sajad, et al.
Publicado: (2020)